Regeneron Pharmaceuticals (REGN) Debt Ratio (2014 - 2026)

Regeneron Pharmaceuticals' Debt Ratio history runs 9 years deep, the most recent figure standing at 0.05 for Q2 2026.

• In Q2 2026, Debt Ratio fell 8.33% year-over-year to 0.05; the TTM figure through Jun 2026 stood at 0.05 (down 8.33% YoY), while the FY2025 annual figure was 0.05, down 6.83% from the prior year.
• Debt Ratio for Q2 2026 stood at 0.05, down from 0.05 in the prior quarter.
• The five-year high for Debt Ratio was 0.08 in Q1 2022, with the low at 0.05 in Q2 2026.
• The 5-year median for Debt Ratio is 0.06 (2024), against an average of 0.06.
• The sharpest annual moves came in 2022 and 2025: Debt Ratio slumped 32.5% in 2022, then dropped 5.51% in 2025.
• Regeneron Pharmaceuticals' Debt Ratio stood at 0.07 in 2022, then declined by 11.62% to 0.06 in 2023, then dropped by 12.33% to 0.05 in 2024, then declined by 6.83% to 0.05 in 2025, then declined by 2.76% to 0.05 in 2026.
• Business Quant data shows REGN's Debt Ratio at 0.05 in Q2 2026, 0.05 in Q1 2026, and 0.05 in Q4 2025.